Literature DB >> 17303642

Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

Shashank M Dravid1, Kevin Erreger, Hongjie Yuan, Katherine Nicholson, Phuong Le, Polina Lyuboslavsky, Antoine Almonte, Ernest Murray, Cara Mosely, Jeremy Barber, Adam French, Robert Balster, Thomas F Murray, Stephen F Traynelis.   

Abstract

We have compared the potencies of structurally distinct channel blockers at recombinant NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors. The IC50 values varied with stereochemistry and subunit composition, suggesting that it may be possible to design subunit-selective channel blockers. For dizocilpine (MK-801), the differential potency of MK-801 stereoisomers determined at recombinant NMDA receptors was confirmed at native receptors in vitro and in vivo. Since the proton sensor is tightly linked both structurally and functionally to channel gating, we examined whether blocking molecules that interact in the channel pore with the gating machinery can differentially sense protonation of the receptor. Blockers capable of remaining trapped in the pore during agonist unbinding showed the strongest dependence on extracellular pH, appearing more potent at acidic pH values that promote channel closure. Determination of pK(a) values for channel blockers suggests that the ionization of ketamine but not of other blockers can influence its pH-dependent potency. Kinetic modelling and single channel studies suggest that the pH-dependent block of NR1/NR2A by (-)MK-801 but not (+)MK-801 reflects an increase in the MK-801 association rate even though protons reduce channel open probability and thus MK-801 access to its binding site. Allosteric modulators that alter pH sensitivity alter the potency of MK-801, supporting the interpretation that the pH sensitivity of MK-801 binding reflects the changes at the proton sensor rather than a secondary effect of pH. These data suggest a tight coupling between the proton sensor and the ion channel gate as well as unique subunit-specific mechanisms of channel block.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303642      PMCID: PMC2075223          DOI: 10.1113/jphysiol.2006.124958

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  102 in total

1.  Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

Authors:  M Hiramatsu; A K Cho; T Nabeshima
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.

Authors:  K T LePage; J E Ishmael; C M Low; S F Traynelis; T F Murray
Journal:  Neuropharmacology       Date:  2005-04-01       Impact factor: 5.250

4.  Dynamics of interstitial and intracellular pH in evolving brain infarct.

Authors:  M Nedergaard; R P Kraig; J Tanabe; W A Pulsinelli
Journal:  Am J Physiol       Date:  1991-03

Review 5.  A review of NMDA receptors and the phencyclidine model of schizophrenia.

Authors:  S A Thornberg; S R Saklad
Journal:  Pharmacotherapy       Date:  1996 Jan-Feb       Impact factor: 4.705

6.  Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.

Authors:  Kevin Erreger; Shashank M Dravid; Tue G Banke; David J A Wyllie; Stephen F Traynelis
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

Review 7.  Evolving concepts about the role of acidosis in ischemic neuropathology.

Authors:  G C Tombaugh; R M Sapolsky
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

8.  Open channel block and alteration of N-methyl-D-aspartic acid receptor gating by an analog of phencyclidine.

Authors:  J G Dilmore; J W Johnson
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

9.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

10.  Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia.

Authors:  A Kochhar; J A Zivin; V Mazzarella
Journal:  J Neurotrauma       Date:  1991       Impact factor: 5.269

View more
  70 in total

Review 1.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

4.  NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies.

Authors:  Georg Köhr
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

5.  Effects of neurosteroid actions at N-methyl-D-aspartate and GABA A receptors in the midbrain ventral tegmental area for anxiety-like and mating behavior of female rats.

Authors:  Cheryl A Frye; Jason J Paris
Journal:  Psychopharmacology (Berl)       Date:  2010-09-28       Impact factor: 4.530

6.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

7.  Hydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors.

Authors:  Jamie A Abbott; Gabriela K Popescu
Journal:  Mol Pharmacol       Date:  2020-06-29       Impact factor: 4.436

8.  A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.

Authors:  Emmanuel Kostakis; Ming-Kuei Jang; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

9.  Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.

Authors:  Feng Yi; Subhrajit Bhattacharya; Charles M Thompson; Stephen F Traynelis; Kasper B Hansen
Journal:  J Physiol       Date:  2019-11-02       Impact factor: 5.182

Review 10.  Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.